BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1090 related articles for article (PubMed ID: 35418578)

  • 1. Targeting non-coding RNAs to overcome cancer therapy resistance.
    Chen B; Dragomir MP; Yang C; Li Q; Horst D; Calin GA
    Signal Transduct Target Ther; 2022 Apr; 7(1):121. PubMed ID: 35418578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-angiogenic Drug Resistance: Roles and Targeting of Non-coding RNAs (microRNAs and long non-coding RNAs).
    Dashtaki ME; Ghasemi S
    Curr Mol Pharmacol; 2023; 16(8):855-869. PubMed ID: 36475334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ncRNADrug: a database for validated and predicted ncRNAs associated with drug resistance and targeted by drugs.
    Cao X; Zhou X; Hou F; Huang YE; Yuan M; Long M; Chen S; Lei W; Zhu J; Chen J; Zhang T; Guo AY; Jiang W
    Nucleic Acids Res; 2024 Jan; 52(D1):D1393-D1399. PubMed ID: 37953323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive review for non-coding RNAs: From mechanisms to therapeutic applications.
    Zhang Y; Zhan L; Jiang X; Tang X
    Biochem Pharmacol; 2024 Jun; 224():116218. PubMed ID: 38643906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response.
    Hashemi M; Rashidi M; Hushmandi K; Ten Hagen TLM; Salimimoghadam S; Taheriazam A; Entezari M; Falahati M
    Pharmacol Res; 2023 Apr; 190():106732. PubMed ID: 36931542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential roles and mechanisms of non-coding RNAs in cancer anoikis resistance.
    Shi T; Zhang C; Xia S
    Mol Cell Biochem; 2022 May; 477(5):1371-1380. PubMed ID: 35142950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-coding RNAs and exosomal ncRNAs in multiple myeloma: An emphasis on molecular pathways.
    Hashemi M; Roshanzamir SM; Paskeh MDA; Karimian SS; Mahdavi MS; Kheirabad SK; Naeemi S; Taheriazam A; Salimimoghaddam S; Entezari M; Mirzaei S; Samarghandian S
    Eur J Pharmacol; 2023 Feb; 941():175380. PubMed ID: 36627099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Role of Non-Coding RNAs in Esophageal Squamous Cell Carcinoma.
    Feng Q; Zhang H; Yao D; Chen WD; Wang YD
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-coding RNAs in disease: from mechanisms to therapeutics.
    Nemeth K; Bayraktar R; Ferracin M; Calin GA
    Nat Rev Genet; 2024 Mar; 25(3):211-232. PubMed ID: 37968332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ncRNA-TGF-β axis: Unveiling new frontiers in colorectal cancer research.
    Alharbi KS
    Pathol Res Pract; 2024 Feb; 254():155138. PubMed ID: 38266458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer.
    Wang Y; Wang Y; Qin Z; Cai S; Yu L; Hu H; Zeng S
    Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):291-306. PubMed ID: 33544643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profile of non-coding RNA-mediated glycolysis control in human cancers.
    Mirzaei S; Ranjbar B; Tackallou SH
    Pathol Res Pract; 2023 Aug; 248():154708. PubMed ID: 37536019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-coding RNAs and potential therapeutic targeting in cancer.
    Toden S; Zumwalt TJ; Goel A
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188491. PubMed ID: 33316377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of non-coding RNAs mediated pyroptosis on cancer therapy: a review.
    Zhao D; Wu T; Tan Z; Xu J; Lu Z
    Expert Rev Anticancer Ther; 2024 May; 24(5):239-251. PubMed ID: 38594965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of noncoding RNAs and untranslated regions in cancer: A review.
    Zhang Y; Yang M; Yang S; Hong F
    Medicine (Baltimore); 2022 Aug; 101(33):e30045. PubMed ID: 35984196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistance.
    Hashemi M; Hasani S; Hajimazdarany S; Mirmazloomi SR; Makvandy S; Zabihi A; Goldoost Y; Gholinia N; Kakavand A; Tavakolpournegari A; Salimimoghadam S; Nabavi N; Zarrabi A; Taheriazam A; Entezari M; Hushmandi K
    Int J Biol Macromol; 2022 Dec; 222(Pt A):1151-1167. PubMed ID: 36191781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-coding RNAs in EMT regulation: Association with tumor progression and therapy response.
    Sadrkhanloo M; Entezari M; Rashidi M; Hashemi M; Raesi R; Saghari S; Daneshi S; Salimimoghadam S; Hushmandi K; Mirzaei S; Taheriazam A
    Eur J Pharmacol; 2022 Oct; 932():175212. PubMed ID: 36055365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging role of noncoding RNAs in the EGFR signaling pathway in lung cancer.
    Mohan S; Hakami MA; Dailah HG; Khalid A; Najmi A; Zoghebi K; Halawi MA
    Pathol Res Pract; 2024 Jan; 253():155016. PubMed ID: 38070221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-coding RNAs and leaf senescence: Small molecules with important roles.
    Li S; Zhao Y; Tan S; Li Z
    Plant Physiol Biochem; 2024 Feb; 207():108399. PubMed ID: 38277833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Hedgehog and Hippo signaling pathways in cancer: A special focus on non-coding RNAs.
    Sharma U; Tuli HS; Uttam V; Choudhary R; Sharma B; Sharma U; Prakash H; Jain A
    Pharmacol Res; 2022 Dec; 186():106523. PubMed ID: 36377125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.